Prediction of acetaminophen-induced hepatotoxicity in acetylcysteine-treated patients using routine admission biomarkers
This study developed and validated a stratified predictive model using only routine admission biomarkers that significantly outperforms the current ALTxAPAP benchmark in identifying acetylcysteine-treated acetaminophen overdose patients at high risk of hepatotoxicity, thereby enabling more precise selection for intensified therapy.